Nine to twelve years. That’s about how long most drug companies have to make serious money on new products before their patent protection ends.

More than a dozen bacterial species among the hundreds that live in people’s mouths have been linked to a collective 50 percent increased chance of developing head and neck squamous cell carcinoma (HNSCC), a new study shows.

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients’ decisions about whether to participate in cancer trials, according to surveys of patients treated at two Baltimore medical centers.

A study found that ChatGPT 3.5, when asked 20 common breast cancer questions, provided inaccurate answers in 24% of cases and lacked reliable references in 41% of responses, emphasizing the need for caution when using AI for medical information.

Older adults undergoing cancer treatment exhibited reduced risk for falling if they had discussions about physical activity with their health care provider, according to study results.

Advocates in the cancer community have long argued that pharmacy benefit managers (PBMs) are inflating the cost of oral oncolytic therapies.

Roughly 635,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International's most recent report.

It's long been known that no amount of alcohol is good for the body — and now new research spotlights the potential harm it can cause.

The Mayo Clinic saved almost $39 million in cancer drug costs and another $10 million in wasted drugs over the course of three years with an automated system that rounds drug doses.

Monday, September 23, The United States House of Representatives passed Congresswoman Harshbarger's H.R. 5526, The Seniors’ Access to Critical Medications Act of 2024 which ensures that medicare seniors have access to the critical medications they need.